iz

Hypoxia, a common feature of the tumor microenvironment, plays a crucial role in tumor progression and therapy resistance. Hypoxia-inducible factors (HIFs) are key transcriptional regulators that mediate cellular responses to hypoxic conditions. In cancer, hypoxia promotes the maintenance and expansion of cancer stem cells (CSCs), a subpopulation of cells implicated in tumor initiation, metastasis, and recurrence. This quantitative analysis investigates the role of HIFs in stem cell maintenance among cancer patients. Utilizing data from clinical studies and experimental models, statistical analyses, including correlation and regression analysis, were conducted to elucidate the relationship between HIF expression, CSC markers, and clinical outcomes. Preliminary analyses revealed a significant correlation between hypoxia-inducible factor expression and the presence of CSC markers in tumor tissues from cancer patients (r = 0.56, p < 0.001). Regression analysis demonstrated a significant association between HIF-1α expression and CSC marker expression (β = 0.35, p < 0.001), as well as overall survival (β = -0.25, p = 0.012). Similarly, HIF-2α expression showed a significant association with CSC marker expression (β = 0.28, p = 0.003) and overall survival (β = -0.21, p = 0.028). Subgroup analyses based on cancer type and stage further elucidated the context-specific roles of HIFs in regulating CSC maintenance and therapeutic resistance. These findings underscore the significance of targeting the hypoxic microenvironment and HIF signaling pathways to disrupt CSCs and improve therapeutic strategies in cancer management.

Keywords: Hypoxia-inducible, Hypoxia Factors, Stem Cell Maintenance, Cancer.